{"disease":{"id":"js001","name":"js001"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04116918","title":"Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Baodong Qin","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}